August 8, 2025 | clinical trials, oncology, patient recruitment
Boosting screening & enrollment rates in a global oncology trial

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Kate Shaw, Innovative Trials Founder & CEO, looks ahead to 2022 by listing three predictions for the clinical trial industry in 2022
World Cancer Day is celebrated around the world in February in February and innovative Trials wants to take this opportunity to raise awareness around cancer
Kate Shaw, Innovative Trials’ Founder & CEO, investigates one of the biggest challenges facing clinical research today.
In this first 2022 blog, the Innovative Trials’ Equality & Diversity committee will be looking at raising awareness around Cervical Cancer
Stop by Booth 1015 to meet the Innovative Trials’ team during SCOPE 2022
2021 has been a very busy year for Innovative Trials and Kate Shaw discusses the main highlights.
In this blog, we look back at the Innovative Trials’ Equality & Diversity (E&D) committee blogs across 2021
How Innovative Trials’ global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical…
In this November blog, Innovative Trials will be looking at the men’s health and the Movember movement which aims at raising awareness around men’s health
